Relmada TherapeuticsRLMD

13F holders, Q4 2024 (December 31)
48holders −21
5new positions
28sold out
1famous investor
$0.52avg. 13F price*

At the end of Q4 2024, 48 institutions reported holding Relmada Therapeutics Inc. (RLMD) in their 13F filings, down 21 from Q3 2024. 5 opened new positions and 28 sold out. The largest holders were Franklin Resources Inc. ($677K), Vanguard Group Inc. ($653K) and Acadian Asset Management LLC ($636K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Relmada Therapeutics Inc.
CUSIP
75955J402
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 93Q1 2024Q2 2024: 79Q2 2024Q3 2024: 69Q3 2024Q4 2024: 48Q4 2024Q1 2025: 44Q1 2025Q2 2025: 50Q2 2025Q3 2025: 44Q3 2025Q4 2025: 78Q4 2025Q1 2026: 103Q1 2026Q2 2026: 126Q2 2026

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions5$71K
Exits28$9.3M

All 13F filers, Q3 2024 → Q4 2024: 759,254 shares bought and 4,764,817 shares sold, net −4,005,563 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 48 holders

Franklin Resources Inc. 0.00% No change 1,302,151 $677K
Vanguard Group Inc. 0.00% No change 1,256,705 $653K
Acadian Asset Management LLC 0.00% Add +3.5% 1,227,928 $636K
BlackRock, Inc. 0.00% Add +4.5% 593,326 $309K
Palo Alto Investors LP 0.04% Reduce -32.4% 495,146 $257K
Geode Capital Management, LLC 0.00% Reduce -0.6% 302,838 $158K
Deutsche Bank AG 0.00% No change 224,846 $117K
UBS Group AG 0.00% Add +70.2% 215,140 $112K
AdvisorShares Investments LLC 0.02% Add +206.5% 210,068 $109K
Bank of America Corp. 0.00% Reduce 0.0% 206,657 $107K
Tang Capital Management LLC 0.01% Add +295.1% 200,825 $104K
Two Sigma Advisers, LP 0.00% Reduce -18.0% 198,900 $103K
Renaissance Technologies 0.00% Add +535.5% 164,513 $86K
Parsons Capital Management Inc. 0.00% Reduce -83.7% 163,336 $85K
RBF Capital, LLC 0.00% Reduce -1.3% 163,261 $85K
Barclays PLC 0.00% No change 145,999 $76K
Two Sigma Investments, LP 0.00% Reduce -33.3% 127,579 $66K
Gsa Capital Partners LLP 0.00% Add +15.1% 124,773 $65K
State Street Corp. 0.00% Add +7.6% 106,735 $56K
Group One Trading LLC 0.00% Add +3.2% 102,087 $53K
Rosalind Advisors, Inc. 0.03% New 100,000 $52K
Mgo One Seven LLC 0.00% No change 100,000 $52K
Northern Trust Corp. 0.00% Add +12.8% 84,282 $44K
Bridgeway Capital Management, LLC 0.00% Reduce -59.9% 72,600 $38K
Citigroup Inc. 0.00% Reduce 0.0% 62,949 $33K
apricus wealth, LLC 0.02% Reduce -38.0% 48,962 $25K
Jacobs Levy Equity Management, Inc. 0.00% Reduce -71.1% 45,602 $24K
Ikarian Capital, LLC 0.01% Reduce -0.3% 40,270 $21K
JPMorgan Chase & Co. 0.00% Reduce -88.0% 37,700 $20K
Sei Investments Co. 0.00% Reduce -0.3% 36,230 $19K
AlTi Global, Inc. 0.00% No change 31,975 $17K
FMR LLC 0.00% Reduce -74.2% 30,062 $16K
World Investment Advisors 0.00% Reduce -9.2% 29,684 $15K
Wealthedge Investment Advisors, LLC 0.01% — 28,000 $15K
Robertson Stephens Wealth Management, LLC 0.00% New 25,000 $13K
Tortoise Investment Management, LLC 0.00% No change 21,676 $11K
Morgan Stanley 0.00% Reduce -54.6% 17,197 $9K
Dimensional Fund Advisors LP 0.00% Reduce -80.3% 14,428 $8K
Algorithmic Investment Models, LLC 0.00% New 11,006 $6K
Sargent Investment Group, LLC 0.00% Reduce -45.6% 11,670 $5K
Bedel Financial Consulting, Inc. 0.00% No change 10,000 $4K
Hexagon Capital Partners LLC 0.00% No change 4,000 $2K
American Capital Advisory, LLC 0.00% No change 1,954 $1K
Tower Research Capital LLC (TRC) 0.00% New 760 $396
Wells Fargo & Company 0.00% Reduce -42.9% 200 $104
SBI Securities Co., Ltd. 0.00% — 102 $53
BNP Paribas Financial Markets 0.00% New 72 $37
Osaic Holdings, Inc. 0.00% Add +18.5% 32 $16

"% of holder's portfolio" is RLMD's weight in each manager's 13F, not the share of Relmada Therapeutics Inc. the manager owns.